Post-meal blood sugar spikes may increase Alzheimer’s risk

A large genetic study has found that sharp rises in blood sugar after meals could significantly heighten the risk of Alzheimer’s disease. Researchers from the University of Liverpool analyzed data from over 350,000 UK Biobank participants, revealing a 69% increased risk linked to postprandial hyperglycemia. The effect appears independent of visible brain damage, pointing to subtler biological mechanisms.

Researchers at the University of Liverpool have uncovered evidence that post-meal blood sugar spikes may pose a greater threat to brain health than previously recognized. In a study published in Diabetes, Obesity and Metabolism in 2025, the team examined genetic and health data from more than 350,000 participants in the UK Biobank, all aged between 40 and 69. The analysis targeted metrics like fasting glucose, insulin levels, and blood sugar two hours after eating, employing Mendelian randomization to determine causal links to dementia.

The results highlighted a strong association between elevated post-meal glucose—termed postprandial hyperglycemia—and Alzheimer’s disease. Participants with higher levels faced a 69% greater risk, a connection not attributable to brain atrophy or white matter lesions. This suggests underlying pathways, possibly involving hidden metabolic effects, that warrant further investigation.

Conditions like type 2 diabetes and insulin resistance have long been tied to cognitive decline, but this research isolates after-meal spikes as a distinct factor. Lead author Dr. Andrew Mason noted, "This finding could help shape future prevention strategies, highlighting the importance of managing blood sugar not just overall, but specifically after meals."

Senior author Dr. Vicky Garfield emphasized the need for validation: "We first need to replicate these results in other populations and ancestries to confirm the link and better understand the underlying biology. If validated, the study could pave the way for new approaches to reduce dementia risk in people with diabetes."

These insights build on prior knowledge of hyperglycemia's role in dementia, potentially informing targeted interventions to safeguard brain health amid rising diabetes rates.

Relaterte artikler

Realistic split-image illustration showing obesity-linked faster rise in Alzheimer’s blood biomarkers versus normal weight, highlighting blood tests detecting changes earlier than brain scans.
Bilde generert av AI

Obesity linked to faster rise in Alzheimer’s blood biomarkers, study finds

Rapportert av AI Bilde generert av AI Faktasjekket

New research finds that blood biomarkers associated with Alzheimer’s disease increase significantly faster in people with obesity than in those without. Drawing on five years of data from 407 volunteers, the study suggests that blood tests can detect obesity‑related changes earlier than brain scans, underscoring obesity as a major modifiable risk factor for Alzheimer’s.

A new genetic study indicates that obesity and high blood pressure directly contribute to dementia, beyond merely raising its risk. Researchers from Denmark and the U.K. used advanced methods to establish this causal link, emphasizing prevention through weight and blood pressure management. The findings suggest early interventions could avert vascular-related dementia.

Rapportert av AI

New research reveals that blood from younger mice can protect against Alzheimer's-like brain damage, while older blood accelerates it. Scientists conducted experiments infusing mouse blood over 30 weeks to observe effects on memory and protein buildup. The findings highlight blood's role in brain health and potential new treatments.

Scientists at Brown University have identified a subtle brain activity pattern that can forecast Alzheimer's disease in people with mild cognitive impairment up to two and a half years in advance. Using magnetoencephalography and a custom analysis tool, the researchers detected changes in neuronal electrical signals linked to memory processing. This noninvasive approach offers a potential new biomarker for early detection.

Rapportert av AI

Researchers have demonstrated that restoring levels of a key brain energy molecule can reverse advanced Alzheimer's disease in mouse models, repairing damage and restoring cognitive function. The study, published on December 22, challenges the long-held view that the condition is irreversible. Findings from human brain tissue support the approach's potential relevance to patients.

New research indicates that poor sleep quality can make the brain age faster than the body, potentially increasing risks for conditions like dementia. Scientists suggest chronic inflammation from inadequate sleep plays a key role in this process. This finding clarifies a long-standing uncertainty about whether bad sleep causes cognitive decline or merely signals it.

Rapportert av AI Faktasjekket

A Mass General Brigham–led study published in Nature Medicine suggests that modest daily walking is associated with delayed cognitive decline among older adults at risk for Alzheimer’s disease. Model-based estimates link 3,000–5,000 daily steps with about a three-year delay and 5,001–7,500 steps with roughly seven years.

 

 

 

Dette nettstedet bruker informasjonskapsler

Vi bruker informasjonskapsler for analyse for å forbedre nettstedet vårt. Les vår personvernerklæring for mer informasjon.
Avvis